CRI

Value Q1, 25 TTM Total revenue 681.11 M 2.95 B Gross profit 293.87 M 1.32 B Operating expenses 268.49 M 1.22 B Selling/general/admin expenses 270.05 M 1.19 B Research & development — — Operating income 28.44 M 146.27 M Non-Operating Income, Total 3.58 M 8.35 M Interest expense, net of interest capitalized 11.76 M 27.25 M Non-Operating Income, excl. Interest Expenses -8.1 M -19.97 M Unusual income/expense -86 K 1.08 M Pretax income 19.86 M 112.34 M Equity in earnings — — Taxes 5.52 M 21.75 M Non-controlling/minority interest — — After tax other income/expense 547 K — Net income before discontinued operations 14.34 M 90.59 M Discontinued operations — — Net income 14.34 M 90.59 M Dilution adjustment — — Preferred dividends — — Diluted net income available to common stockholders 13.94 M 88.18 M Basic earnings per share (Basic EPS) 0.39 2.49 Diluted earnings per share (Diluted EPS) 0.39 2.49 Average basic shares outstanding 35.49 M — Diluted shares outstanding 35.5 M — EBITDA 422.17 M 1.06 B EBIT 409.48 M 1.01 B Cost of revenue 3.14 M 719.39 M Other cost of goods sold 3.14 M 2.16 M Depreciation & amortization (cash flow) 12.68 M 51.89 M